Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.

Alphabet (Google) is investing in biotech penny stocks. Should you? Explore Alphabet's investment strategy and discover potential penny stocks to consider.

If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...

Key Insights Significant control over IO Biotech by private equity firms implies that the general public has more ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...

Discover why IBB's focused approach makes it preferable to XBI. Learn about their objectives, diversification, and ...

Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wanted data good enough to ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

JNJ eyes Q2 growth with strong drug sales and new launches, but Stelara biosimilars and MedTech headwinds loom.

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.